Literature DB >> 18338107

Ocular relapse in acute myeloid leukemia (M4) with normal bone marrow.

Hayyam Kiratli1, Haluk Demiroğlu, Serkan Emeç.   

Abstract

A patient with the rare occurrence of ocular relapse of acute myeloid leukemia (AML) M4 while the bone marrow was normal is reported in this paper. A 47-year-old woman with AML was treated with chemotherapy and went successfully into remission. Four months later, she presented with pain, redness, and a mass over the left eye. The ocular relapse involved the subconjunctival space and anterior chamber of the left eye and, presumably, the left lacrimal gland. There were also multiple subcutaneous nodules on both of her forearms. Incisional biopsy from the subconjunctival lesion was performed. Histopathological examination of the specimen showed diffuse blast cell infiltration. Her bone marrow was still in remission. Although exceedingly rare, ocular extramedullary relapse in AML M4 heralds bone marrow recurrence and, despite intensive chemotherapy, the prognosis is dismal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338107     DOI: 10.1007/s10792-008-9207-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Isolated central nervous system relapse in acute myeloid leukaemia.

Authors:  H Demiroglu; S Dundar
Journal:  N Z Med J       Date:  1996-06-28

Review 2.  Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.

Authors:  Y Koc; K B Miller; D P Schenkein; P Daoust; K Sprague; E Berkman
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

3.  Ocular adnexal granulocytic sarcoma as the first sign of acute myelogenous leukemia relapse.

Authors:  F Yaghouti; M Nouri; G E Mannor
Journal:  Am J Ophthalmol       Date:  1999-03       Impact factor: 5.258

Review 4.  Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation.

Authors:  W Y Au; Y L Kwong; A K Lie; S K Ma; R Liang
Journal:  Hematol Oncol       Date:  1999-06       Impact factor: 5.271

Review 5.  Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.

Authors:  J C Byrd; W J Edenfield; D J Shields; N A Dawson
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

6.  Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.

Authors:  A N Békássy; J Hermans; N C Gorin; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  1996-05       Impact factor: 5.483

  6 in total
  6 in total

Review 1.  Is acute myeloid leukemia a liquid tumor?

Authors:  Maro Ohanian; Stefan Faderl; Farhad Ravandi; Naveen Pemmaraju; Guillermo Garcia-Manero; Jorge Cortes; Zeev Estrov
Journal:  Int J Cancer       Date:  2013-02-04       Impact factor: 7.396

2.  Ocular granulocytic sarcoma: a case report and literature review of ocular extramedullary acute myeloid leukemia.

Authors:  Maro Ohanian; Gautam Borthakur; Alfonso Quintas-Cardama; Michael Mathisen; Jorge E Cortés; Zeev Estrov; Naveen Pemmaraju
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-25

3.  Acute Unilateral Hypopyon Uveitis and Secondary Glaucoma in an Adult With Relapsing Acute Lymphoblastic Leukemia.

Authors:  Mithun Thulasidas; Sagarika Patyal
Journal:  Cureus       Date:  2022-05-13

4.  Ocular Manifestations of Leukemia and Results of Treatment with Intravitreal Methotrexate.

Authors:  Vicktoria Vishnevskia-Dai; Sara Sella King; Ruth Lekach; Ido Didi Fabian; Ofira Zloto
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

5.  Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report.

Authors:  Joong Hyun Park; Yengwoo Son; Joon Young Hyon; Ji Yun Lee; Hyun Sun Jeon
Journal:  BMC Ophthalmol       Date:  2022-02-10       Impact factor: 2.209

6.  Acute Myeloid Leukemia Relapse Presenting as Complete Monocular Vision Loss due to Optic Nerve Involvement.

Authors:  Shyam A Patel
Journal:  Case Rep Hematol       Date:  2016-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.